InsidersTradesSigma
Explore the full directors' dealings record of Knight Therapeutics Inc., a publicly traded company based in Canada. Shares are listed on CA CA, under the supervision of SEDI. Market capitalisation: €903.3m. The latest transaction was reported on 5 June 2026 (38 - Redemption, retraction, cancellation, repurchase). Among the most active insiders: Knight Therapeutics Inc.. The full history is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
4 of 4 declarations